OSI Systems signs partnership agreement with Irish software firm, dabl

OSI Systems, Inc. (NASDAQ:OSIS), a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has entered into an agreement with Irish software firm, dabl^® Ltd. Under the terms of the agreement Spacelabs will promote and offer for sale the dabl® 24 hour ambulatory blood pressure monitoring (“ABPM”) software in conjunction with its ambulatory blood pressure monitors to general practitioners and pharmacies in the United Kingdom and Italy.

OSI Systems CEO, Deepak Chopra, stated, "Spacelabs has long been considered the ‘gold standard’ equipment provider for ABPM monitoring equipment within the acute care and hospital markets. This new partnership with dabl^®, initially for the United Kingdom and Italy, enables primary healthcare practitioners and local pharmacies the ability to provide fast, reliable and interpretive reports to dramatically help improve patient care and management."

Uncontrolled blood pressure is one of the highest risk factors for strokes, heart attacks, cognitive impairment and a range of other cardiovascular conditions. Medical research now shows that relying solely on a one-off blood pressure test can be highly inaccurate. Current guidelines specify that the most accurate measurement for blood pressure is over a 24-hour period, commonly called ABPM. Traditionally the use of ABPM was restricted to specialist centers that had the expertise to interpret the data.

The dabl^® ABPM system automatically interprets the data making this important investigation accessible to general practice and pharmacy and improving the overall standard of reporting. The dabl^® ABPM system is used in over 1,000 clinics and pharmacies worldwide and is considered the gold standard by the medical experts. The combined 24-hour blood pressure measurement solution from dabl^® and Spacelabs provides a real solution to address the potential errors and inaccuracies that can be associated with traditional blood pressure measurement, thus allowing for improved blood pressure control that will prevent stroke and heart attack.